IL1B and rheumatoid arthritis: However, IL-35 also exerts pro-inflammatory effects by activating the production of IL-12 and IFN-γ (15), and its expression is upregulated in autoimmune diseases such as rheumatoid arthritis (RA) where it augments the release of pro-inflammatory factors such as IL-1β and IL-6 (16).